ã©ã€ããµã€ãšã³ã¹äŒæ¥ã§ãã Emergent BioSolutions Inc. ã¯ãå¶çºçãæå³çãããã³èªç¶çºççãªå
¬è¡è¡çäžã®è
åš (PHT) ã«å¯ŸåŠããããã®æºåããã³å¯Ÿå¿è£œåãšãœãªã¥ãŒã·ã§ã³ã®æäŸã«éç¹ã眮ããŠããŸããå瀟ã®è£œåã¯ãååŠçãçç©åŠçãæŸå°ç·åŠçãæ žçãççºç©ãå«ã PHTãæ°èææçãæ
è¡äžã®å¥åº·ãæ°èã®å¥åº·å±æ©ã𿥿§/ç·æ¥å»çã«å¯Ÿå¿ããŠããŸããå瀟ã¯ã倩ç¶çã¯ã¯ãã³ã® ACAM2000ãççœèã¯ã¯ãã³ã® BioThraxãã³ã¬ã©ã¯ã¯ãã³ã® Vaxchoraãããã³è
žããã¹ã¯ã¯ãã³ã® Vivotif ãæäŸããŠããŸããå瀟ã¯ãŸããæ¢ç¥ãŸãã¯çããããªããªã€ãéå°æåã®ç·æ¥æ²»ççšã® NARCANãããã³åå¿æ§ç®è逿ããŒã·ã§ã³ ããããæäŸããŠããŸããããã«ãåžå
¥æ§ççœèã®æ²»çãšäºé²ã®ããã® raxibacumabãåžå
¥æ§ççœèã®æ²»ççšã® Anthrasil ãæäŸããŠããŸããå瀟ã¯ããããªãã¹çã®æ²»çã®ããã®äžäŸ¡ãããªãã¹ææ¯çŽ ã倩ç¶çã¯ã¯ãã³ã®å䜵çã«å¯ŸåŠããéæ³šçšã¯ã¯ã·ãã¢å
ç«ã°ãããªã³ãããã³è¬å€ãšããã€ã¹ã®èªå泚å°åšã®è€å補ååè£ã§ãããããã¬ãŒããéçºããŠãããããã«ãå瀟ã¯ãSARS-CoV-2ã®æ²»çã®ããã®COVID-EIGãšCOVID-HIGãå£ç¯æ§ã€ã³ãã«ãšã³ã¶AãŠã€ã«ã¹ã®æ²»çã®ããã®FLU-IGIVãççœèã¯ã¯ãã³åè£ã®AV7909ããã¯ã³ã°ãã¢ãŠã€ã«ã¹VLPã¯ã¯ãã³ã®CHIKV VLPããžã«ãŠã€ã«ã¹æ²»çè¬åè£ã®ZIKV-IGãETECæåãçºçŸããèµ€ç¢èã¯ã¯ãã³ã®Shigella-ETECãã©ããµç±ã®ãã¯ã¿ãŒã¯ã¯ãã³ã®EBS-LASVãäžèœã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®UNI-FLUãããŒã«ãã«ã°ãŠã€ã«ã¹ç
ã®æ²»çã®ããã®ãã¯ã¿ãŒã¯ã¯ãã³ã®rVSV-Marburgãã¹ãŒãã³ãŠã€ã«ã¹ç
ã®æ²»çã®ããã®ãã¯ã¿ãŒã¯ã¯ãã³ã®rVSV-SudanãéçºããŠããããžãããªã¢ææ¯çŽ ã® DATããªã·ã³ææ¯çŽ ã® Ricin-IGããšãã©/ã¹ãŒãã³ ã¢ãã¯ããŒãã«æäœã® Pan-Ebola ãªã©ãããŸããŸãªææ¯çŽ ã補é ããŠããŸããããã«ãéçºãµãŒãã¹ãè¬ç©åæè£œé ãè¬ç©è£œå補é ãããªãå¥çŽéçºè£œé ãµãŒãã¹ãæäŸããŠããŸããEmergent BioSolutions Inc. 㯠1998 幎ã«èšç«ãããã¡ãªãŒã©ã³ãå·ã²ã€ãµãŒãºããŒã°ã«æ¬ç€Ÿã眮ããŠããŸãã